Redefining MTBDRplus test results: what do indeterminate results actually mean?
- 1 February 2016
- journal article
- research article
- Published by International Union Against Tuberculosis and Lung Disease in The International Journal of Tuberculosis and Lung Disease
- Vol. 20 (2), 154-159
- https://doi.org/10.5588/ijtld.15.0319
Abstract
BACKGROUND: Although line-probe assays (LPAs) are promising, little research has been conducted to elucidate the true nature of indeterminate LPA results or assess the ability of these assays to perform on a wide range of clinical samples. OBJECTIVE: To evaluate the performance of the commercially available GenoType® MTBDRplus LPA against conventional BACTEC™ MGIT™ 960 culture and drug susceptibility testing (DST) among 308 pulmonary tuberculosis (PTB) and 32 extra-pulmonary TB samples. RESULTS: Invalid LPA results (defined as those with a missing Mycobacterium tuberculosis identification band) were obtained for 18 PTB samples, which were excluded from further analysis. The sensitivity and specificity of the MTBDRplus assay for multidrug-resistant TB, based upon the results obtained for the remaining 322 samples, was respectively 95.2% and 95.1%. Of 290 PTB samples, 40 (13.7%) were indeterminate on LPA (defined as the absence of both wild-type and corresponding mutation bands) for isoniazid (INH) and/or rifampicin (RMP), and were further evaluated by pyrosequencing (PSQ). Contrary to standard LPA interpretation, INH and RMP susceptibility were confirmed by both DST and PSQ in respectively 7.5% (3/40) and 27.5% (11/40) of indeterminate samples. CONCLUSION: PSQ was found to be a valuable and rapid technique to resolve discrepancies in LPA test results that were not interpretable.This publication has 34 references indexed in Scilit:
- Validation of the GenoType® MTBDRplus assay for detection of MDR-TB in a public health laboratory in ThailandBMC Infectious Diseases, 2010
- Pyrosequencing for Rapid Detection of Mycobacterium tuberculosis Resistance to Rifampin, Isoniazid, and FluoroquinolonesJournal of Clinical Microbiology, 2009
- Performance Assessment of the GenoType MTBDR plus Test and DNA Sequencing in Detection of Multidrug-Resistant Mycobacterium tuberculosisJournal of Clinical Microbiology, 2009
- Direct susceptibility testing for multi drug resistant tuberculosis: A meta-analysisBMC Infectious Diseases, 2009
- Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South AfricaJournal of Antimicrobial Chemotherapy, 2008
- Multidrug-resistant tuberculosis: rapid detection of resistance to rifampin and high or low levels of isoniazid in clinical specimens and isolatesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2008
- Genotype MTBDR plus : a Further Step toward Rapid Identification of Drug-Resistant Mycobacterium tuberculosisJournal of Clinical Microbiology, 2008
- Molecular epidemiology and prevalence of mutations conferring rifampicin and isoniazid resistance in Mycobacterium tuberculosis strains from the southern UkraineClinical Microbiology & Infection, 2007
- Evaluation of the Genotype MTBDR Assay for Rapid Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis IsolatesJournal of Clinical Microbiology, 2006
- Comparison of Two Commercially Available DNA Line Probe Assays for Detection of Multidrug-Resistant Mycobacterium tuberculosisJournal of Clinical Microbiology, 2006